Sweden
· Delayed Price · Currency is SEK Alteco Medical AB Statistics
Total Valuation
Alteco Medical AB has a market cap or net worth of SEK 16.83 million. The enterprise value is 23.88 million.
| Market Cap | 16.83M |
| Enterprise Value | 23.88M |
Important Dates
The last earnings date was Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Alteco Medical AB has 107.19 million shares outstanding. The number of shares has decreased by -11.99% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 107.19M |
| Shares Change (YoY) | -11.99% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 66.88% |
| Owned by Institutions (%) | 0.03% |
| Float | 17.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.50 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.34 |
| EV / Sales | 7.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.68
| Current Ratio | 0.68 |
| Quick Ratio | 0.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33.26 |
Financial Efficiency
Return on equity (ROE) is -439.99% and return on invested capital (ROIC) is -70.21%.
| Return on Equity (ROE) | -439.99% |
| Return on Assets (ROA) | -48.34% |
| Return on Capital (ROIC) | -70.21% |
| Revenue Per Employee | 851,574 |
| Profits Per Employee | -1.78M |
| Employee Count | 4 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 0.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.64% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -63.64% |
| 50-Day Moving Average | 0.17 |
| 200-Day Moving Average | 0.23 |
| Relative Strength Index (RSI) | 48.67 |
| Average Volume (20 Days) | 117,953 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Alteco Medical AB had revenue of SEK 3.41 million and -7.14 million in losses. Loss per share was -0.13.
| Revenue | 3.41M |
| Gross Profit | 1.35M |
| Operating Income | -6.86M |
| Pretax Income | -7.14M |
| Net Income | -7.14M |
| EBITDA | -6.64M |
| EBIT | -6.86M |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 200,828 in cash and 7.25 million in debt, giving a net cash position of -7.05 million or -0.07 per share.
| Cash & Cash Equivalents | 200,828 |
| Total Debt | 7.25M |
| Net Cash | -7.05M |
| Net Cash Per Share | -0.07 |
| Equity (Book Value) | -1.10M |
| Book Value Per Share | -0.02 |
| Working Capital | -3.12M |
Cash Flow
| Operating Cash Flow | -7.36M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 39.50%, with operating and profit margins of -201.41% and -209.58%.
| Gross Margin | 39.50% |
| Operating Margin | -201.41% |
| Pretax Margin | -209.58% |
| Profit Margin | -209.58% |
| EBITDA Margin | -194.98% |
| EBIT Margin | -201.41% |
| FCF Margin | n/a |
Dividends & Yields
Alteco Medical AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 11.99% |
| Shareholder Yield | 11.99% |
| Earnings Yield | -83.75% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Alteco Medical AB has an Altman Z-Score of -17.04. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.04 |
| Piotroski F-Score | n/a |